These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases]. Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087 [TBL] [Abstract][Full Text] [Related]
6. Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma. Buchner A; Pohla H; Willimsky G; Frankenberger B; Frank R; Baur-Melnyk A; Siebels M; Stief CG; Hofstetter A; Kopp J; Pezzutto A; Blankenstein T; Oberneder R; Schendel DJ Hum Gene Ther; 2010 Mar; 21(3):285-97. PubMed ID: 19788391 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now? Bedke J; Stenzl A Expert Rev Anticancer Ther; 2013 Dec; 13(12):1399-408. PubMed ID: 24215158 [TBL] [Abstract][Full Text] [Related]
8. IMA901: a peptide vaccine in renal cell carcinoma. Bedke J; Stenzl A Expert Opin Investig Drugs; 2013 Oct; 22(10):1329-36. PubMed ID: 23899354 [TBL] [Abstract][Full Text] [Related]
9. Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Nelson WG; Simons JW; Mikhak B; Chang JF; DeMarzo AM; Carducci MA; Kim M; Weber CE; Baccala AA; Goeman MA; Clift SM; Ando DG; Levitsky HI; Cohen LK; Sanda MG; Mulligan RC; Partin AW; Carter HB; Piantadosi S; Marshall FF Cancer Chemother Pharmacol; 2000; 46 Suppl():S67-72. PubMed ID: 10950151 [TBL] [Abstract][Full Text] [Related]
10. Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine. Zhou X; Jun DY; Thomas AM; Huang X; Huang LQ; Mautner J; Mo W; Robbins PF; Pardoll DM; Jaffee EM Cancer Res; 2005 Feb; 65(3):1079-88. PubMed ID: 15705910 [TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of multipeptide cancer vaccine IMA901 after single-dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long-term follow up. Hongo F; Ueda T; Takaha N; Tamada S; Nakatani T; Miki T; Ukimura O Int J Urol; 2023 Feb; 30(2):176-180. PubMed ID: 36305687 [TBL] [Abstract][Full Text] [Related]
12. Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer. Aruga A; Takeshita N; Kotera Y; Okuyama R; Matsushita N; Ohta T; Takeda K; Yamamoto M Clin Cancer Res; 2013 Apr; 19(8):2224-31. PubMed ID: 23479678 [TBL] [Abstract][Full Text] [Related]
15. Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses. Zhou J; Weng D; Zhou F; Pan K; Song H; Wang Q; Wang H; Wang H; Li Y; Huang L; Zhang H; Huang W; Xia J Cancer Immunol Immunother; 2009 Oct; 58(10):1587-97. PubMed ID: 19221746 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial. Baek S; Kim CS; Kim SB; Kim YM; Kwon SW; Kim Y; Kim H; Lee H J Transl Med; 2011 Oct; 9():178. PubMed ID: 22013914 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic gene modified cell based cancer vaccines. Kozłowska A; Mackiewicz J; Mackiewicz A Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846 [TBL] [Abstract][Full Text] [Related]